In this episode, Dr. Chris Beck speaks with Dr. Martijn Meijerink of Amsterdam UMC about the COLLISION Trial, which compares thermal ablation to surgical resection in the treatment of metastatic colorectal cancer. The discussion examines the trial’s design, outcomes, and implications for evolving treatment paradigms in interventional oncology. The experts also highlight advancements in ablation techniques, considerations for standardizing procedural quality, and the growing role of minimally invasive approaches in multidisciplinary cancer care.
Contributors:
Dr. Christopher Beck is a practicing interventional radiologist with Regional Radiology Group in New Orleans.
Dr. Martijn Meijerink is an interventional radiologist and primary investigator of the COLLISION Trial at UMC Amsterdam.